ÂÜÀòÂÒÂ×

David Krempa is a seasoned professional in the pharmaceutical industry, having held various key positions in business development and investor relations at reputable companies such as Eton Pharmaceuticals, Sagent Pharmaceuticals, and Akorn, Inc. Prior to their roles in the pharmaceutical sector, Krempa worked as an Equity Analyst at Morningstar. David is an alumnus of DePaul University.